Durgical
EN
Open the app

Skin effects of cancer treatment

  • Disease group

Cancer drugs and radiation often affect the skin, hair and nails. Most reactions can be managed so that the life-saving treatment continues.

Updated

See it in 3D: Skin

What it is

Cytotoxic chemotherapy damages fast-dividing cells: hair loss (anagen effluvium), mucositis, nail lines and lifting, hand-foot syndrome, hyperpigmentation and tissue necrosis if a vesicant leaks out of the vein. Targeted drugs block pathways the skin also uses: EGFR inhibitors cause an acne-like rash, dry skin, nail-fold inflammation and hair changes; multikinase inhibitors cause a painful callus-like hand-foot skin reaction; BRAF inhibitors cause warty growths and squamous cell carcinomas. Immune checkpoint inhibitors release T cells that may attack the skin: itchy rashes, lichenoid and psoriasis-like eruptions, vitiligo-like depigmentation, bullous pemphigoid and, rarely, SJS/TEN. Radiotherapy causes radiation dermatitis confined to the treated field, and later thinning, telangiectasia and fibrosis. Months to years later, chronic radiation dermatitis leaves thin, dry, hairless, mottled skin with telangiectasia and woody fibrosis; its small vessels are scarred, so it heals poorly, and minor trauma or surgery in the field can leave a chronic ulcer. A non-healing ulcer or a new nodule in an old field can be a cancer (squamous or basal cell carcinoma, or rarely angiosarcoma after breast radiotherapy), like the Marjolin ulcer that arises in old burn scars, so it is biopsied.

How to recognise it

  • EGFR inhibitor rash: follicular papules and pustules on face, scalp and upper trunk in the first weeks; no comedones; later dry skin, painful nail-fold inflammation and long curly eyelashes.
  • Hand-foot syndrome (cytotoxics): symmetrical painful redness and swelling of palms and soles that may blister and peel.
  • Hand-foot skin reaction (multikinase inhibitors): localised thick, yellow, painful callus-like plaques on pressure points.
  • Chemotherapy hair loss: diffuse, starting within weeks of the first cycles; it usually regrows after treatment ends.
  • Radiation dermatitis: redness, then dry and then moist peeling strictly within the treated field, worst in skin folds.
  • Checkpoint inhibitor reactions: itchy maculopapular rash is the commonest; lichenoid, psoriasis-like and vitiligo-like patterns and bullous pemphigoid also occur.
  • Emergency signs on any cancer drug: blisters, mucosal erosions, skin pain, fever, facial swelling.
  • Chronic radiation dermatitis: thin, dry, hairless skin with telangiectasia, mottled pigment and fibrosis inside the old field; it heals poorly because its small vessels are scarred.
  • A radiated ulcer that does not heal, bleeds, grows or has raised edges needs a biopsy: chronic wounds in damaged skin can turn into squamous cell carcinoma (Marjolin-type), and radiation fields also give basal cell carcinoma and angiosarcoma.

How it happens

  1. Cytotoxic drugs kill rapidly dividing cells; the matrix of growing hairs stops and the hair shaft breaks.
  2. Some cytotoxics reach high levels in the palms and soles, where friction and heat add damage: hand-foot syndrome.
  3. EGFR blockade disturbs keratinocyte growth and follicle maturation: follicular inflammation, dry skin, fragile nails.
  4. Checkpoint blockade (PD-1, PD-L1, CTLA-4) releases T cells that attack melanocytes, keratinocytes or the basement membrane.
  5. Radiation damages DNA in basal keratinocytes and small vessels in the beam: erythema and peeling, later fibrosis.
  6. The reaction is graded by severity; the oncologist decides whether to continue, pause or change treatment.
  7. Months to years later, scarring of the small vessels leaves hypoxic, fibrotic skin with few cells able to repair it, so wounds break down and heal slowly.

Common skin reactions to cancer treatment

ReactionTypical causeWhat it looks likeKey point
Acneiform rashEGFR inhibitors (cetuximab, erlotinib, gefitinib)Follicular papules and pustules on face and upper trunkNo comedones; not acne
Hand-foot syndromeCapecitabine, fluorouracil, liposomal doxorubicinDiffuse symmetrical red, painful palms and solesDiffuse; may blister
Hand-foot skin reactionMultikinase inhibitors (sorafenib and similar)Localised painful callus-like plaques at pressure pointsLocalised; pare calluses beforehand
Chemotherapy hair lossAnthracyclines, taxanes, alkylating agentsDiffuse loss within weeksUsually regrows
Radiation dermatitisRadiotherapyRedness and peeling with sharp field bordersOnly in the beam
Checkpoint inhibitor rashPembrolizumab, nivolumab, ipilimumabItchy rash, lichenoid papules, white patches, tense blistersBlisters or erosions = urgent
Chronic radiation dermatitis and ulcerRadiotherapy, months to years earlierThin, shiny, hairless skin, telangiectasia, fibrosis; ulcer that will not healBiopsy a non-healing ulcer: cancer can arise in it

In the clinic

  • Prevention starts on day one of EGFR inhibitors: emollients, gentle cleansers, sun protection; oncology teams often add an anti-inflammatory tetracycline.
  • Avoid acne drying agents on the EGFR rash; they irritate an already dry, fragile skin.
  • Hand-foot reactions: avoid friction and heat, use urea emollients, cushion pressure points, and pare thick calluses before multikinase inhibitors start.
  • Radiation dermatitis: gentle washing, emollients, no friction; moist peeling needs non-adherent dressings.
  • Hair loss has a strong emotional impact; discuss wigs, scarves and, where available, scalp cooling before treatment starts.
  • Radiation wounds: protect the field from trauma and sun, treat infection and use moist dressings; deep or large ulcers may need excision and cover with a flap of healthy, non-irradiated tissue, and some centres add hyperbaric oxygen.

Next step

  • Grade the reaction (extent, symptoms, effect on daily life) and photograph it to follow the course.
  • Swab pustules or nail-fold inflammation that worsen for bacterial culture, and erosions for herpes PCR.
  • Blisters, mucosal erosions, skin pain, fever or facial swelling: emergency assessment for SJS/TEN or DRESS.
  • Refer severe or persistent reactions to dermatology so the cancer treatment can continue; any change to the cancer drug is the oncologist's decision.
  • Biopsy the edge of any ulcer in a radiation field that has not healed within about three months, or any new nodule there, and refer to dermatology or plastic surgery.

Common traps

  • The EGFR inhibitor rash is acne: it has no comedones, comes from blocked EGFR in the follicle, and acne drying agents worsen it.
  • A skin reaction means the cancer drug must stop: most are mild to moderate and are treated while the drug continues; the oncologist decides from the grade.
  • Hand-foot syndrome and hand-foot skin reaction are the same: cytotoxics cause diffuse redness; multikinase inhibitors cause localised calluses on pressure points.
  • A rash on a checkpoint inhibitor is always mild: blisters, mucosal erosions or fever can mean SJS/TEN or bullous pemphigoid and need urgent care.
  • A chronic ulcer in an old radiation field is just poor healing: radiated skin heals badly, but a non-healing ulcer can be a squamous cell carcinoma (Marjolin-type) or another radiation-induced cancer, so the edge is biopsied.

Test yourself

Think of the answer, then tap the question to see it.

A patient on an EGFR inhibitor has facial papules and pustules but no comedones. Why should acne drying agents be avoided?

It is a follicular inflammation from blocked EGFR in skin that is already dry and fragile; drying agents irritate it. Emollients, sun protection and anti-inflammatory treatment are used.

Why does chemotherapy hair loss start within weeks and usually reverse?

Cytotoxics stop the dividing matrix of growing hairs, which break; the follicle stem cells survive, so hair regrows once treatment ends.

A patient with melanoma on a checkpoint inhibitor develops white patches. What do they mean?

Vitiligo-like depigmentation: released T cells attack melanocytes, which share antigens with the melanoma; it is associated with a better tumour response.

A woman treated with chest radiotherapy 15 years ago has an ulcer in the field that has not healed in four months. Why biopsy it?

Radiated skin heals poorly, but chronic wounds in damaged skin can turn malignant (squamous cell carcinoma, Marjolin-type) and the field can also give basal cell carcinoma or angiosarcoma; a biopsy of the edge rules cancer out.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of dermatology

Educational content; it does not replace assessment by a doctor or dermatologist and is not a clinical instruction. For a rash with fever, painful skin, blisters or peeling, sores in the mouth or eyes, or a swelling throat, go to an emergency department at once.

Sources: Acneiform Eruptions (StatPearls Publishing (NCBI Bookshelf), 2024); Alopecia (StatPearls Publishing (NCBI Bookshelf), 2024); Skin and Nail Changes during Cancer Treatment (National Cancer Institute (cancer.gov), 2024); Radiation Therapy Side Effects (National Cancer Institute (cancer.gov), 2024); Marjolin Ulcer (StatPearls (NCBI Bookshelf), 2025).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.